12月30日，生物股份大宗交易成交14.79万股，成交额240.04万元，占当日总成交额的0.4%，成交价 16.23元，较市场收盘价15元溢价8.2%。 ...

证券之星消息，12月30日动物保健板块较上一交易日下跌0.91%，生物股份领跌。当日上证指数报收于 3965.12，下跌0.0%。深证成指报收于13604.07，上涨0.49%。动物保健板块个股涨跌见下表： 从资金流向上来看，当日动物保健板块主力资金净流出1.05亿元，游资资金净流入4812.36万元，散户资 金净流入5735.09万元。动物保健板块个股资金流向见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 002141 | 赔丰控股 | 3.83 | 4.08% | 37.86万 | 1.44亿 | | 300119 | 瑞普生物 | 19.19 | 0.00% | 3.36万 | 6454.17万 | | 603566 | 普莱柯 | 12.50 | -0.16% | 2.70万 | 3375.65万 | | 920729 | 永顺生物 | 8.68 | -0.23% | 4725.43 | 409.76万 | | 300871 | 回盛生物 | 20.64 | -0.29% | ...

Core Viewpoint - The stock of Bio Co., Ltd. has experienced significant fluctuations, with a year-to-date increase of 120.79% but a recent decline of 10.77% over the past five trading days, indicating volatility in investor sentiment and market performance [1]. Company Performance - As of September 30, 2025, Bio Co., Ltd. reported a revenue of 1.042 billion yuan, reflecting a year-on-year growth of 7.38%, while the net profit attributable to shareholders decreased by 4.85% to 161 million yuan [2]. - The company has a cumulative cash distribution of 2.219 billion yuan since its A-share listing, with 189 million yuan distributed over the past three years [3]. Shareholder Information - The number of shareholders for Bio Co., Ltd. decreased by 10.70% to 49,000, while the average number of circulating shares per person increased by 11.12% to 22,673 shares [2]. - Notable institutional shareholders include Guotai CSI Livestock Breeding ETF, which increased its holdings by 9.09 million shares, and Hong Kong Central Clearing Limited, which added 1.094 million shares [3]. Market Activity - The stock price of Bio Co., Ltd. was reported at 15.08 yuan per share, with a market capitalization of 16.765 billion yuan. The trading volume was 83.7786 million yuan, with a turnover rate of 0.50% [1]. - The stock has appeared on the "Dragon and Tiger List" four times this year, with the most recent instance on December 24, where it recorded a net buy of -63.219 million yuan [1].

Group 1 - The stock of Jin Yu Biological Technology Co., Ltd. decreased by 1.3% on December 30, trading at 15.19 yuan per share, with a total market capitalization of 16.887 billion yuan [1] - The company, established on March 13, 1993, and listed on January 15, 1999, primarily engages in the research, production, and sales of veterinary biological products, with main business revenue composition being 94.42% from biopharmaceuticals, 3.18% from other income, and 2.40% from supplementary sources [1] Group 2 - The fund under招商基金 holds a significant position in Jin Yu Biological, with the 招商中证畜牧养殖ETF (516670) increasing its holdings by 834,000 shares in the third quarter, totaling 3.6029 million shares, which represents 3.95% of the fund's net value, ranking as the eighth largest holding [2] - The 招商中证畜牧养殖ETF (516670) was established on March 18, 2021, with a current size of 878 million yuan, yielding a return of 13.79% this year, ranking 3260 out of 4195 in its category, and a one-year return of 11.04%, ranking 3318 out of 4179 [2] Group 3 - The fund manager of 招商中证畜牧养殖ETF (516670) is Liu Chongjie, who has been in the position for 7 years and 242 days, managing total assets of 32.873 billion yuan, with the best fund return during his tenure being 102.53% and the worst being -35.89% [3]

Investment Rating - Industry Rating: Recommended [4] Core Insights - The pork industry continues to face losses, with a focus on pig farming opportunities. The average price of live pigs is 11.59 CNY/kg, down 0.46% week-on-week. The total breeding sow inventory is 39.9 million heads, down 1.1% month-on-month and 2.1% year-on-year. The industry is experiencing ongoing losses, with self-bred and purchased pig farming losses at 130.11 CNY/head and 162.80 CNY/head respectively. The recent anti-dumping ruling may alleviate domestic pork supply pressure, leading to accelerated capacity reduction [2][12]. Summary by Sections Planting Industry Chain - The Ministry of Agriculture and Rural Affairs has initiated winter crop seed supervision checks to ensure seed safety for the upcoming spring and summer planting. The checks focus on key crops such as corn, rice, soybeans, cotton, and vegetables. The commercialization of genetically modified technology is expected to accelerate, enhancing self-sufficiency rates of key varieties. Recommended stocks include Beidahuang and Suqian Agricultural Development [1][11]. Pig Farming - The average price of live pigs is reported at 11.59 CNY/kg, with a slight decrease of 0.46% from the previous week. The average price for pig futures is 11,469 CNY/ton, reflecting a 1.07% increase. The average weight of pigs post-slaughter is 89.57 kg, with a month-on-month increase of 3.21% in slaughter volume [12][62][65]. Recommended Stocks - For pig farming, recommended stocks include: 1. Livestock sector: Lihua Stock, Muyuan Food, Shuanghui Development, Dekang Agriculture, Jingji Zhino, and Wens Foodstuff 2. Feed sector: Haida Group 3. Animal health sector: Jinhai Biological, Biological Shares, Placo, and Zhongmu Shares [2][12].

Investment Rating - The report maintains an "Overweight" rating for the agriculture, forestry, animal husbandry, and fishery industry [1][42] Core Views - The SW agriculture, forestry, animal husbandry, and fishery industry slightly underperformed the CSI 300 index, with an increase of 1.55% from December 12 to December 25, 2025, lagging behind the index by approximately 0.43 percentage points [11][14] - All sub-sectors recorded positive returns during the same period, with notable increases in agricultural product processing (3.04%), animal health (2.95%), planting (2.28%), fishery (1.56%), breeding (0.81%), and feed (0.29%) [14][15] - The overall price-to-book (PB) ratio for the industry is approximately 2.79 times, indicating a slight recovery in valuation, which remains at a historical low level, around the 62.7 percentile since 2006 [18][24] Industry Important Data - **Pig Farming**: The average price of external three-way cross pigs increased from 11.45 CNY/kg to 11.59 CNY/kg during the reporting period. The cost of corn and soybean meal has slightly decreased, with corn priced at 2338.04 CNY/ton and soybean meal at 3102 CNY/ton as of December 25, 2025 [22][24] - **Profitability**: As of December 26, 2025, the profit for self-bred pigs was -130.11 CNY/head, and for purchased piglets, it was -162.8 CNY/head, showing a reduction in losses compared to the previous two weeks [27] - **Poultry Farming**: The average price of broiler chicks was 3.59 CNY/chick, showing a slight increase, while the average price for white feather broilers was 7.82 CNY/kg, with profitability improving to 0.89 CNY/chick [29][33] Industry Insights - The report emphasizes the potential for a rebound in pig prices as the seasonal consumption peak approaches, with a focus on the high inventory of breeding sows and the opportunities for leading pig farming companies [42][43] - In poultry farming, the report highlights the recovery in white feather broiler prices and the improvement in profitability, suggesting a positive outlook for leading poultry companies [42][43] - The report also notes growth potential in the domestic pet market and the expected increase in export volumes, recommending attention to promising domestic leaders in this sector [42][43]

证券之星消息，12月26日动物保健板块较上一交易日下跌1.01%，生物股份领跌。当日上证指数报收于 3963.68，上涨0.1%。深证成指报收于13603.89，上涨0.54%。动物保健板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 600195 | 中牧股份 | 8.00 | 0.13% | 9.70万 | 7760.85万 | | 920729 | 永顺生物 | 8.83 | 0.11% | 4509.29 | 398.88万 | | 002141 | 后丰控股 | 3.71 | -0.27% | 15.43万 | 5712.69万 | | 300119 | 瑞普生物 | 19.37 | -0.31% | 2.94万 | 5701.35万 | | 688526 | 科前生物 | 15.62 | -0.38% | 1.90万 | 2965.26万 | | 688098 | 申联生物 | 8.91 | -0.67% | 2.81万 | 2511.39万 | | 603566 ...

Group 1 - The company has signed a maximum guarantee contract with China Everbright Bank for a total guarantee amount of RMB 10 million for its wholly-owned subsidiary, Qingdao Kangdian Animal Pharmaceutical Co., Ltd. [1][5] - The guarantee was approved by the company's board of directors on April 25, 2025, and subsequently by the annual shareholders' meeting on May 16, 2025 [2][6] - The guarantee covers all debts, including principal, interest, penalties, and other related costs incurred by the subsidiary [3][5] Group 2 - The necessity of the guarantee is justified as it supports the subsidiary's business development and operational needs, aligning with the company's overall interests and strategic development [6] - The subsidiary has a debt-to-asset ratio below 70%, allowing the company to effectively control operational risks and decision-making [6] - As of the announcement date, the total amount of external guarantees provided by the company and its subsidiaries is RMB 1.2302 billion, which accounts for 70.79% of the audited net assets attributable to shareholders as of December 31, 2024 [6][7]

Group 1 - The core announcement is regarding the major shareholder, Inner Mongolia Jinyu Biological Holdings Co., Ltd., planning to increase its stake in Jinyu Biotechnology Co., Ltd. with a total investment of no less than RMB 50 million and no more than RMB 100 million within 12 months from the announcement date [1][2] - The increase in shares is supported by a special loan commitment from China Minsheng Bank, which will provide a loan of up to RMB 90 million for the share purchase, with a loan term of 36 months [2] - The remaining funds for the share increase will come from the major shareholder's own resources, indicating a strong commitment to the company's long-term value [2] Group 2 - The announcement emphasizes the confidence of the major shareholder in the company's future stable development and long-term investment value [1] - The company assures that the announcement does not contain any false records, misleading statements, or major omissions, and takes legal responsibility for the accuracy and completeness of the content [1] - The company will fulfill its information disclosure obligations if any risks arise during the implementation of the share increase plan [2]

Summary of Key Points Core Viewpoint - On December 24, several A-share listed companies disclosed their shareholding changes, with notable increases in holdings from companies like Guizhou Moutai and others, while 18 companies reported reductions in their shareholdings [1][3]. Group 1: Shareholding Increases - **Biological Shares**: Major shareholder obtained a commitment letter for a special loan to increase holdings [2]. - **Marter Shares**: The controlling shareholder and chairman Liu Aisen plans to increase holdings by no less than 100 million yuan [2]. - **Guizhou Moutai**: Plans to repurchase shares through centralized bidding [2]. - **Donghong Shares**: Plans to repurchase shares worth between 30 million to 60 million yuan [2]. Group 2: Shareholding Reductions - **Kaifa Electric**: Shareholders Zhao Le, Wen Guowang, and Zhang Xiaoyi plan to reduce holdings by no more than 0.70% [2]. - **Zhuhai Guanyu**: Shareholders Ningbo Huijin and Zhuhai Lengquan plan to reduce holdings by no more than 3% [2]. - **Lite New Materials**: Controlling shareholder Wang Kunming plans to reduce holdings by no more than 3% [2]. - **Sanhui Electric**: Shareholder Wu Baofu plans to reduce holdings by no more than 2% [2]. - **Xuedilong**: Plans to reduce no more than 4.8856 million shares of repurchased stock [2]. - **Jindun Shares**: Shareholder Gaoxin Investment plans to reduce holdings by no more than 1%, and Founder Securities plans to reduce by no more than 3% [2]. - **Tianhai Defense**: China Great Wall Asset reduced holdings by 3.0278 million shares from December 22 to December 23 [2]. - **Zhangyuan Tungsten**: Controlling shareholder's reduction plan has been completed [2]. - **Chaojie Shares**: Controlling shareholder reduced 974,400 shares from December 8 to December 24 [2]. - **Hengdian East Magnetic**: Controlling shareholder plans to reduce holdings by no more than 1% [2]. - **Luxin Investment**: Controlling shareholder Luxin Group plans to reduce holdings by no more than 1% [2]. - **Sunglow Power**: Four shareholders collectively reduced 423,700 shares [2]. - **He富中国**: Controlling shareholder He富 Hong Kong reduced 9,000 shares on December 24 [2]. - **Tuojing Technology**: The largest shareholder, the National Fund, reduced 1.83 million shares from December 17 to December 24 [2]. - **Little Bear Electric**: Shareholder Long Shaohong plans to reduce holdings by no more than 0.64% [2]. - **Chao Xun Communication**: Shanghai Jiuyi Investment Management reduced holdings to 4.99% [2]. - **Caesar Travel**: The third largest shareholder, Jingu Trust, plans to reduce holdings by no more than 3% [2].